Results 201 to 210 of about 4,963,319 (355)

Implementation of pharmacists' monitoring for intravenous drug compatibility. [PDF]

open access: yesEur J Hosp Pharm, 2023
Cheon YJ   +7 more
europepmc   +1 more source

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

open access: yesAdvanced Healthcare Materials, EarlyView.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales   +11 more
wiley   +1 more source

Broken Intraluminal Needle in an Intravenous Drug User - A Case Report and Review. [PDF]

open access: yesJ Orthop Case Rep, 2023
Seth A, Bansal N, Tiwari P, Jain S.
europepmc   +1 more source

Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM‐I against influenza A Virus Infection

open access: yesAdvanced Healthcare Materials, EarlyView.
This study explores nanoparticle delivery of the protein kinase C inhibitor bisindolylmaleimide‐I (BIM‐I) to combat influenza A virus infections. Encapsulation in biodegradable PLGA nanoparticles improved safety while maintaining the compound's strong antiviral activity.
Laura Klement   +12 more
wiley   +1 more source

AIDS and Intravenous Drug Abusers [PDF]

open access: yesBritish Journal of Addiction, 1986
openaire   +2 more sources

Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal

open access: yesJournal of Medical Virology, 2011
R. Calado   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy